JP6635974B2 - エピナスチン含有点眼液 - Google Patents

エピナスチン含有点眼液 Download PDF

Info

Publication number
JP6635974B2
JP6635974B2 JP2017085128A JP2017085128A JP6635974B2 JP 6635974 B2 JP6635974 B2 JP 6635974B2 JP 2017085128 A JP2017085128 A JP 2017085128A JP 2017085128 A JP2017085128 A JP 2017085128A JP 6635974 B2 JP6635974 B2 JP 6635974B2
Authority
JP
Japan
Prior art keywords
ophthalmic solution
salt
acid
epinastine
preservative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017085128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018070582A5 (https=
JP2018070582A (ja
Inventor
昌宏 河畑
昌宏 河畑
松本　直樹
直樹 松本
博行 井上
博行 井上
共紀 原
共紀 原
祥江 日景
祥江 日景
隆司 森本
隆司 森本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP2017085128A priority Critical patent/JP6635974B2/ja
Publication of JP2018070582A publication Critical patent/JP2018070582A/ja
Publication of JP2018070582A5 publication Critical patent/JP2018070582A5/ja
Application granted granted Critical
Publication of JP6635974B2 publication Critical patent/JP6635974B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2017085128A 2017-04-24 2017-04-24 エピナスチン含有点眼液 Active JP6635974B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017085128A JP6635974B2 (ja) 2017-04-24 2017-04-24 エピナスチン含有点眼液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017085128A JP6635974B2 (ja) 2017-04-24 2017-04-24 エピナスチン含有点眼液

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016211535A Division JP6134853B1 (ja) 2016-10-28 2016-10-28 エピナスチン含有点眼液

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019227272A Division JP6736752B2 (ja) 2019-12-17 2019-12-17 エピナスチン含有点眼液

Publications (3)

Publication Number Publication Date
JP2018070582A JP2018070582A (ja) 2018-05-10
JP2018070582A5 JP2018070582A5 (https=) 2019-12-05
JP6635974B2 true JP6635974B2 (ja) 2020-01-29

Family

ID=62113544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017085128A Active JP6635974B2 (ja) 2017-04-24 2017-04-24 エピナスチン含有点眼液

Country Status (1)

Country Link
JP (1) JP6635974B2 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
JPWO2015125921A1 (ja) * 2014-02-20 2017-03-30 わかもと製薬株式会社 保存効力を有する医薬用水性組成物

Also Published As

Publication number Publication date
JP2018070582A (ja) 2018-05-10

Similar Documents

Publication Publication Date Title
JP6134853B1 (ja) エピナスチン含有点眼液
RU2745317C2 (ru) Фармацевтическая композиция, включающая дорзоламид и бримонидин
US10632202B2 (en) Preservative containing compositions
JP6736752B2 (ja) エピナスチン含有点眼液
JP2023093601A (ja) 眼科用製品
JP6635974B2 (ja) エピナスチン含有点眼液
JP7191022B2 (ja) アルカフタジン又はその塩を含有する水性医薬組成物
JP2024096345A (ja) エピナスチン含有点眼液
JP6877196B2 (ja) メグルミン又はその塩からなる防腐剤
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
WO2024135837A1 (ja) 組織移行性及び防腐効力を向上させるエピナスチン含有水性組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191025

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191025

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20191025

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20191106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191119

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191217

R150 Certificate of patent or registration of utility model

Ref document number: 6635974

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250